皮肤科用静脉注射免疫球蛋白。第 2 部分：临床适应证和结果。
Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.
机构信息
Chelsea and Westminster Hospital, London, UK.
Dermatological Surgery and Laser Unit, St John's Institute of Dermatology, Guy's Hospital Cancer Centre, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK.
出版信息
Clin Exp Dermatol. 2018 Aug;43(6):659-666. doi: 10.1111/ced.13552. Epub 2018 May 17.
Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In part two of this review, we assess the clinical indications of IVIg in dermatological disorders and the outcomes of its use.
静脉注射免疫球蛋白（IVIg）是一种人免疫球蛋白、盐、糖和溶剂的溶液，用于治疗多种疾病。尽管 IVIg 已被证明可安全有效地治疗许多疾病，但支持其使用的随机对照试验相对较少。在本综述的第二部分，我们评估了 IVIg 在皮肤科疾病中的临床适应证及其使用效果。
Zotero 插件